ATC code N04BX03 (WHO) PubChem CID 68778 UNII L9026OPI2Z | CAS Number 57982-78-2 ChemSpider 62021 Molar mass 293.446 g/mol | |
 | ||
AHFS/Drugs.com International Drug Names | ||
Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[1]
While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.
Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.
References
Budipine Wikipedia(Text) CC BY-SA